FDA Widens Probe of McNeil Drugs

WASHINGTON, May 18 (UPI) — The federal government says it’s expanding an investigation that led to the shutdown of a Johnson & Johnson drug plant in Fort Washington, Pa.

Johnson & Johnson closed the plant this month and recalled about 50 children’s versions of non-prescription drugs, including Tylenol, Motrin and Benadryl, made at the plant by the company’s McNeil Consumer Healthcare unit.

The children’s products could contain tiny metal particles, an incorrect amount of ingredients and ingredients that don’t meet testing requirements, McNeil said in its recall.

The recall of the children’s medicines was the third by McNeil since September.

The U.S. Food and Drug Administration said Monday it now is conducting a companywide investigation to determine whether similar problems exist at other McNeil plants.

McNeil, in an e-mail Monday to CNNMoney.com, said the company was cooperating with the FDA and conducting its own quality assessment.

Copyright 2010 United Press International, Inc. (UPI). Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI’s prior written consent.

Categorized | Other
Leave a Reply

You must be logged in to post a comment.